NUVA

NuVasive Inc.

Price

return (12m)

p/e

73.92

p/bv

2.36

DIVIDEND YIELD

0.00%

NUVA price

NuVasive

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NUVA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals NUVA

Valuation

P/E

73.92

Sector 1.09

Industry -1.78

P/BV

2.36

Sector 1.86

Industry 1.35

P/Revenue (PSR)

1.72

Sector 1.55

Industry 2.25

EV/EBITDA

87.19

Sector -47.62

Industry -42.38

EV/EBIT

-535.10

Sector -27.52

Industry -45.58

P/EBITDA

29.73

Sector -32.64

Industry -23.10

P/EBIT

-30.30

Sector -43.02

Industry -27.18

P/Total Assets

1.01

Sector 0.87

Industry 0.82

P/Net Current Assets

Sector -27.09

Industry -72.46

P/Working Capital

Sector -4.05

Industry -2.10

EPS

0.54

Sector -0.70

Industry -1.11

BVPS

16.87

Sector 4.34

Industry 2.54

Efficiency

Gross Margin

71.66%

Sector 49.36%

Industry 50.48%

EBITDA Margin

8.91%

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

-1.45%

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

7.42%

Sector -19.73%

Industry -25.75%

Net Profit Margins

2.32%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.15

Sector 0.13

Industry 0.06

Profitability

ROE

3.19%

Sector -24.32%

Industry -33.33%

ROA

1.36%

Sector -24.41%

Industry -45.72%

ROIC

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

Sector 1.90

Industry 2.51

Net Debt / EBITDA

12.89

Sector -4.96

Industry -8.98

Net Debt / EBIT

-79.10

Sector -3.08

Industry -37.38

Net Debt / Equity

0.41

Sector -0.45

Industry -1.16

Gross Debt / Equity

0.50

Sector -0.74

Industry -0.56

Equity/Assets

0.43

Sector 0.46

Industry 0.52

Liabilities/Assets

0.43

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

1.49%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals NUVA

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF NuVasive ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.00

Fair Value

$14.32

Upside

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NUVA NuVasive Inc.	$0.00	-	0.00%	73.92	2.36	3.19%	2.32%
ISRG Intuitive Surgical Inc.	$392.49	-9.49%	0.00%	44.01	7.60	17.26%	28.62%
ABT Abbott Laboratories	$102.63	-21.99%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.33	1.59%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$43.52	-55.82%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$87.47	-27.00%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$227.07	-15.55%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$512.11	-20.09%	0.00%	35.48	25.07	70.67%	25.03%
COHR Coherent Inc.	$308.78	198.60%	0.00%	75.62	5.36	7.09%	11.19%
SYK Stryker Corp.	$276.81	-25.56%	1.26%	28.38	4.41	15.55%	14.43%
PHG Koninklijke Philips NV	$24.65	-8.23%	4.11%	18.19	1.78	9.80%	6.30%
INMD InMode Ltd.	$14.32	-4.12%	0.00%	10.90	1.34	12.32%	20.69%
DXCM DexCom Inc.	$88.64	15.96%	0.00%	33.89	12.92	38.14%	20.12%
BDX Becton Dickinson and Company	$180.03	-1.10%	2.34%	52.21	2.01	3.86%	6.30%
EW Edwards Lifesciences Corp.	$88.26	17.37%	0.00%	50.69	4.74	9.36%	15.41%
ALGN Align Technology Inc.	$147.59	14.02%	0.00%	27.43	2.68	9.77%	9.99%
SNN Smith & Nephew PLC	$27.54	-23.70%	2.80%	19.48	4.52	23.22%	9.83%
IRMD iRadimed Corporation	$82.52	17.96%	1.54%	45.76	10.37	22.66%	26.70%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NUVA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT NuVasive

NuVasive Inc.

Average Investor10 user rating

4.0 (0 people)

United States

29 years

Founded: 1997

2004

Time since IPO - 22 years

2.700

Employees

NuVasive Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.10 billion, with shareholders equity totaling $892.54 million.

The company employs approximately 2.700 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, NuVasive Inc. reported $1.23 billion in revenue, generating net income of $28.45 million.

Key financial metrics include a P/E ratio of 73.92, a price-to-book (P/B) ratio of 2.36, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NUVA.

Market cap

$2.10 billion

Net worth

$892.54 million

$892,543,000.00

Assets

$2.09 billion

$2,089,550,000.00

Total Shares Outstanding

52.91 million

52,907,000

Average Daily Trading Volume

$1.56 million

$1,563,890.38

Sector

Health

Industry

Medical Supplies and Equipment

NUVA

NUVA revenue and profits

Financial Results NUVA

DRAG THE FRAME TO SEE MORE DATA

NUVA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.45 21,79% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.31 --3,58% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.99 107,71% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$384.07 54,21% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.38 --7,54% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,142.35 52,87% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$429.56 7,48% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$139.78 15,92% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35